#JiangsuHengruiPharma has chalked up a first-in-class approval for retlirafusp alfa, a #bifunctionaldrug that targets #PDL1 and #TGFbeta, as a treatment for advanced #gastriccancer.
pharmaphorum.com/news/hengrui...
pharmaphorum.com/news/hengrui...
January 8, 2026 at 12:52 PM
#JiangsuHengruiPharma has chalked up a first-in-class approval for retlirafusp alfa, a #bifunctionaldrug that targets #PDL1 and #TGFbeta, as a treatment for advanced #gastriccancer.
pharmaphorum.com/news/hengrui...
pharmaphorum.com/news/hengrui...
#GSK has moved to shore up its R&D #pipeline with a strategic-level deal with China's #JiangsuHengruiPharma that spans a dozen drug candidates and could be worth up to $12.5 billion.
pharmaphorum.com/news/gsk-for...
pharmaphorum.com/news/gsk-for...
GSK forges $12bn alliance with China's Hengrui
GSK has moved to shore up its R&D pipeline with a strategic-level partnering deal with China's Jiangsu Hengrui Pharma.
pharmaphorum.com
July 28, 2025 at 10:05 AM
#GSK has moved to shore up its R&D #pipeline with a strategic-level deal with China's #JiangsuHengruiPharma that spans a dozen drug candidates and could be worth up to $12.5 billion.
pharmaphorum.com/news/gsk-for...
pharmaphorum.com/news/gsk-for...